Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
Quick Stats
Feb 02, 202653.4
AI Score
HOLD0.67
Volume Ratio
Mar 05, 2026
Next Earnings
13
+ve Days (30d)
17
-ve Days (30d)
NUVB Stock Summary
Last updated Feb 02, 2026
NUVB is currently trading at $5.63, positioned above its 200-day moving average of $4.09, indicating a long-term uptrend. The stock has a 52-week range of $1.54 to $9.75.
Technical Analysis: The 50-day moving average stands at $7.62, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 34.98, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.17, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NUVB at 53.4/100 with a HOLD recommendation.
NUVB (Nuvation Bio Inc.) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 34.98 |
| CMF (20) | -0.17 |
| ROC (10) | -3.761 |
| ADX (14) | 38.755 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.686 |
| AROONOSC (14) | -92.857 |
| WILLAMS %R (14) | -66.113 |
| MFI (14) | 15.871 |
NUVB Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NUVB Price vs Max Options Open Interest
NUVB Max Change In Options Open Interest
NUVB Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NUVB Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NUVB Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NUVB Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Nuvation Bio Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
NUVB Moving Averages Analysis
Nuvation Bio Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
NUVB (Nuvation Bio Inc.) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 5.61 |
| 20 | 6.49 |
| 30 | 7.38 |
| 50 | 7.62 |
| 100 | 5.83 |
| 200 | 4.09 |
NUVB Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.8 billion |
| Earnings/Share ($) | -0.48 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.45 |
| EPS Estimate Next Year ($) | 0.55 |
| WallStreet Target Price ($) | 11.8889 |
| Most Recent Quarter |